APA (7th ed.) Citation

Khan, M. S., Butler, J., Anker, S. D., Filippatos, G., Ferreira, J. P., Pocock, S. J., . . . Packer, M. (2023). Impact of empagliflozin in heart failure with reduced ejection fraction in patients with ischemic versus nonischemic cause. Journal of the American Heart Association, 12(1), . https://doi.org/10.1161/JAHA.122.027652

Chicago Style (17th ed.) Citation

Khan, Muhammad Shahzeb, et al. "Impact of Empagliflozin in Heart Failure with Reduced Ejection Fraction in Patients with Ischemic Versus Nonischemic Cause." Journal of the American Heart Association 12, no. 1 (2023). https://doi.org/10.1161/JAHA.122.027652.

MLA (9th ed.) Citation

Khan, Muhammad Shahzeb, et al. "Impact of Empagliflozin in Heart Failure with Reduced Ejection Fraction in Patients with Ischemic Versus Nonischemic Cause." Journal of the American Heart Association, vol. 12, no. 1, 2023, https://doi.org/10.1161/JAHA.122.027652.